quantitative methodologies

Patients

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

News

Roche is paying $700m upfront for rights to bexobrutideg, a BTK degrader that it says has potential across oncology, immunology, and neurology.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.